Personalis is a biotechnology company that specializes in cancer genomics. It develops the NeXT, a platform that offers tumor and normal tissue profiling to provide healthcare professionals with insights into a patient's cancer biology. The company also provides genome sequencing and data analysis services to support the development of cancer therapies.